These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

926 related items for PubMed ID: 16264177

  • 1. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL, Hemminki K.
    J Natl Cancer Inst; 2005 Nov 02; 97(21):1575-9. PubMed ID: 16264177
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M, Reilly M, Czene K.
    J Natl Cancer Inst; 2008 Sep 17; 100(18):1318-25. PubMed ID: 18780865
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J, Hemminki K.
    Breast Cancer Res Treat; 2007 Oct 17; 105(2):229-36. PubMed ID: 17115107
    [Abstract] [Full Text] [Related]

  • 7. Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database.
    Hemminki K, Chen B.
    Prostate; 2005 Oct 01; 65(2):188-94. PubMed ID: 15948149
    [Abstract] [Full Text] [Related]

  • 8. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):116-22. PubMed ID: 16418514
    [Abstract] [Full Text] [Related]

  • 9. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A, Bermejo JL, Sundquist J, Hemminki K.
    Eur J Cancer; 2010 Mar 18; 46(4):752-7. PubMed ID: 20022238
    [Abstract] [Full Text] [Related]

  • 10. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
    Bratt O, Garmo H, Adolfsson J, Bill-Axelson A, Holmberg L, Lambe M, Stattin P.
    J Natl Cancer Inst; 2010 Sep 08; 102(17):1336-43. PubMed ID: 20724726
    [Abstract] [Full Text] [Related]

  • 11. Time trends and familial risks in squamous cell carcinoma of the skin.
    Hemminki K, Zhang H, Czene K.
    Arch Dermatol; 2003 Jul 08; 139(7):885-9. PubMed ID: 12873883
    [Abstract] [Full Text] [Related]

  • 12. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.
    J Natl Cancer Inst; 2008 Dec 17; 100(24):1771-9. PubMed ID: 19066271
    [Abstract] [Full Text] [Related]

  • 13. Effect of paternal and maternal cancer on cancer in the offspring: a population-based study.
    Hemminki K, Vaittinen P.
    Cancer Epidemiol Biomarkers Prev; 1997 Dec 17; 6(12):993-7. PubMed ID: 9419393
    [Abstract] [Full Text] [Related]

  • 14. Incidence and familial risks in pituitary adenoma and associated tumors.
    Hemminki K, Försti A, Ji J.
    Endocr Relat Cancer; 2007 Mar 17; 14(1):103-9. PubMed ID: 17395979
    [Abstract] [Full Text] [Related]

  • 15. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
    Thellenberg C, Malmer B, Tavelin B, Grönberg H.
    J Urol; 2003 Apr 17; 169(4):1345-8. PubMed ID: 12629357
    [Abstract] [Full Text] [Related]

  • 16. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH, Seersholm N, Boice JD, Krüger Kjaer S, Fraumeni JF.
    Br J Cancer; 1999 Feb 17; 79(3-4):673-9. PubMed ID: 10027348
    [Abstract] [Full Text] [Related]

  • 17. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA.
    J Natl Cancer Inst; 2006 Dec 06; 98(23):1694-706. PubMed ID: 17148771
    [Abstract] [Full Text] [Related]

  • 18. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 19. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
    Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J, Melbye M.
    J Natl Cancer Inst; 2010 Jun 02; 102(11):793-801. PubMed ID: 20424236
    [Abstract] [Full Text] [Related]

  • 20. Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database.
    Hemminki K, Chen B.
    Melanoma Res; 2006 Apr 02; 16(2):191-5. PubMed ID: 16567975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.